UHS · Universal Health Services Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · UHS

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$17.36B	$15.83B	$14.28B	$13.40B	$12.64B	$11.56B
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
R&D	-	-	-	-	-	-
SG&A	-	-	-	-	-	-
Total Operating Expenses	$15.37B	$14.15B	$13.11B	$12.40B	$11.28B	$10.20B
D&A	$618.74M	$584.83M	$568.04M	$581.86M	$533.21M	$510.49M
Operating Income	$1.99B	$1.68B	$1.18B	$1.00B	$1.36B	$1.36B
Interest Expense	$156.07M	$186.11M	$206.67M	$126.89M	$83.67M	$106.28M
Income Tax	$460.96M	$334.83M	$221.12M	$209.28M	$305.68M	$299.29M
Net Income	$1.49B	$1.14B	$717.79M	$675.61M	$991.59M	$943.95M
EPS - Basic	$23.42	$17.16	$10.35	$9.23	$11.99	$11.06
EPS - Diluted	$23.10	$16.82	$10.23	$9.14	$11.82	$10.99

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$137.80M	$125.98M	$119.44M	$102.82M	$115.30M	$1.22B
Accounts Receivable	$2.60B	$2.18B	$2.24B	$2.02B	$1.75B	$1.73B
Inventory	-	-	-	-	-	-
Accounts Payable	$750.13M	$632.00M	$613.97M	$636.60M	$658.90M	$570.52M
Current Assets	$3.41B	$2.82B	$2.81B	$2.54B	$2.26B	$3.28B
Total Assets	$15.53B	$14.47B	$13.97B	$13.49B	$13.09B	$13.48B
Current Liabilities	$3.24B	$2.21B	$2.01B	$1.91B	$1.98B	$2.48B
Long-term Debt	$4.00B	$4.46B	$4.79B	$4.73B	$4.14B	$3.52B
Total Liabilities	-	-	-	-	-	-
Stockholders' Equity	$7.28B	$6.67B	$6.15B	$5.92B	$6.09B	$6.32B
Retained Earnings	$7.99B	$7.37B	$6.80B	$6.53B	$6.60B	$6.75B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$1.86B	$2.07B	$1.27B	$996.02M	$883.70M	$2.36B
Investing Cash Flow	($1.07B)	($911.11M)	($763.27M)	($647.30M)	($914.47M)	($802.56M)
Financing Cash Flow	($749.73M)	($1.14B)	($493.94M)	($318.40M)	($1.07B)	($384.86M)
CapEx	$1.02B	$943.81M	$743.05M	$734.00M	$855.66M	$731.31M
Free Cash Flow	$849.25M	$1.12B	$524.74M	$262.02M	$28.04M	$1.63B

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	-	-	-	-	-	-
Operating margin	11.5%	10.6%	8.2%	7.5%	10.8%	11.8%
EBITDA margin	15.0%	14.3%	12.2%	11.8%	15.0%	16.2%
Net margin	8.6%	7.2%	5.0%	5.0%	7.8%	8.2%
Free cash flow margin	4.9%	7.1%	3.7%	2.0%	0.2%	14.1%
FCF / Net income	0.57	0.98	0.73	0.39	0.03	1.73
R&D / Revenue	-	-	-	-	-	-
SG&A / Revenue	-	-	-	-	-	-
Effective tax rate	23.6%	22.7%	23.6%	23.7%	23.6%	24.1%
Return on assets	9.6%	7.9%	5.1%	5.0%	7.6%	7.0%
Return on equity	20.5%	17.1%	11.7%	11.4%	16.3%	14.9%
Return on invested capital	13.5%	11.7%	8.2%	7.2%	10.2%	10.5%
Liquidity
Current ratio	1.05	1.27	1.40	1.33	1.14	1.32
Quick ratio	1.05	1.27	1.40	1.33	1.14	1.32
Cash ratio	0.04	0.06	0.06	0.05	0.06	0.49
Leverage
Debt / Equity	0.55	0.67	0.78	0.80	0.68	0.56
Debt / Assets	0.26	0.31	0.34	0.35	0.32	0.26
Debt / EBITDA	1.53	1.97	2.75	2.98	2.18	1.89
Interest coverage	12.8x	9.0x	5.7x	7.9x	16.3x	12.8x
Equity multiplier	2.13	2.17	2.27	2.28	2.15	2.13
Liabilities / Assets	-	-	-	-	-	-
Efficiency
Asset turnover	1.12	1.09	1.02	0.99	0.97	0.86
Inventory turnover	-	-	-	-	-	-
Days sales outstanding	55d	50d	57d	55d	50d	55d
Days inventory outstanding	-	-	-	-	-	-
Days payable outstanding	-	-	-	-	-	-
Cash conversion cycle	-	-	-	-	-	-
Valuation
P / E	9.4x	10.7x	14.9x	15.4x	11.0x	12.5x
P / B	1.9x	1.8x	1.7x	1.8x	1.8x	1.9x
P / S	0.8x	0.8x	0.7x	0.8x	0.9x	1.0x
EV / EBITDA	6.9x	7.3x	8.8x	9.5x	7.8x	7.5x
Growth
Revenue growth (YoY)	9.7%	10.8%	6.6%	6.0%	9.4%	1.6%
Revenue CAGR (3y)	9.0%	7.8%	7.3%	5.6%	9.0%	3.6%
Revenue CAGR (5y)	8.5%	6.8%	7.9%	5.2%	5.3%	5.0%
Gross profit growth (YoY)	-	-	-	-	-	-
Operating income growth (YoY)	18.6%	43.1%	17.1%	-26.4%	0.3%	11.7%
Net income growth (YoY)	30.4%	59.1%	6.2%	-31.9%	5.0%	15.8%
EPS growth (YoY)	37.3%	64.4%	11.9%	-22.7%	7.6%	20.4%
EPS CAGR (3y)	36.2%	12.5%	-2.4%	0.0%	12.5%	12.1%
EPS CAGR (5y)	16.0%	13.0%	4.2%	3.2%	10.6%	10.2%
FCF growth (YoY)	-24.4%	114.1%	100.3%	834.6%	-98.3%	102.5%
FCF CAGR (5y)	-12.2%	6.9%	-4.9%	-16.0%	-48.4%	20.5%
Book value growth (YoY)	9.1%	8.4%	3.9%	-2.8%	-3.6%	14.8%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$17.42B total

Acute Care Hospital Services$9.93B · 57.0%

Behavioral Health Services$7.43B · 42.6%

State Medicaid Programs$56.00M · 0.3%

All Other Segments$13.42M · 0.1%

Product / service

$12.85B total

Managed Care$3.26B · 25.4%

Health Care$1.91B · 14.9%

Managed Medicare$1.66B · 12.9%

Medicare$1.54B · 12.0%

Medicaid$1.34B · 10.4%

UKRevenue$1.00B · 7.8%

Other Non Patient Revenue$864.33M · 6.7%

Managed Medicaid$685.08M · 5.3%

Other Patient Revenue And Adjustments Net$584.53M · 4.6%

Investment Advice$5.60M · 0.0%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

7/9

Strong

✓Net income positive
✓Operating cash flow positive
✓ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✗Current ratio improved
✓No share dilution
-Gross margin improved
✓Asset turnover improved

Peer comparison

Same SIC group: Services-General Medical & Surgical Hospitals, NEC

Company	Revenue (last FY)	Net margin	ROE
HCA	$75.60B	9.0%	-112.6%
THC	$21.31B	11.1%	56.1%
SGRY	-	-	-4.5%
CYH	$12.48B	4.1%	-36.5%
ARDT	$6.32B	2.1%	10.5%

Comparing UNIVERSAL HEALTH SERVICES INC against the 5 most active filers in the same SIC group.

Dividends

$0.60/share trailing 12 months · -25.0% YoY

Ex-date	Per share
Mar 2, 2026	$0.2000
Dec 1, 2025	$0.2000
Sep 2, 2025	$0.2000
Jun 2, 2025	$0.2000
Mar 3, 2025	$0.2000
Dec 3, 2024	$0.2000
Sep 3, 2024	$0.2000
Jun 3, 2024	$0.2000
Feb 29, 2024	$0.2000
Nov 30, 2023	$0.2000
Aug 31, 2023	$0.2000
May 31, 2023	$0.2000
Feb 28, 2023	$0.2000
Nov 30, 2022	$0.2000
Aug 31, 2022	$0.2000
May 31, 2022	$0.2000
Feb 28, 2022	$0.2000
Nov 30, 2021	$0.2000
Aug 31, 2021	$0.2000
Jun 1, 2021	$0.2000
Mar 12, 2021	$0.2000
Feb 28, 2020	$0.2000
Dec 4, 2019	$0.2000
Aug 30, 2019	$0.2000